alendronate has been researched along with Tooth Loss in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Tooth Loss: The failure to retain teeth as a result of disease or injury.
Excerpt | Relevance | Reference |
---|---|---|
"Because the severity of alveolar bone loss increases with age, it has long been hypothesized that it may, in part, be related to systemic conditions that also predispose the patient to osteoporosis/osteopenia." | 2.40 | Osteoporosis: a possible modifying factor in oral bone loss. ( Jeffcoat, MK, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Earnshaw, SA | 1 |
Keating, N | 1 |
Hosking, DJ | 1 |
Chilvers, CE | 1 |
Ravn, P | 1 |
McClung, M | 1 |
Wasnich, RD | 1 |
Jeffcoat, MK | 1 |
1 review available for alendronate and Tooth Loss
Article | Year |
---|---|
Osteoporosis: a possible modifying factor in oral bone loss.
Topics: Alendronate; Alveolar Bone Loss; Bone Density; Estrogen Replacement Therapy; Female; Humans; Male; M | 1998 |
1 trial available for alendronate and Tooth Loss
Article | Year |
---|---|
Tooth counts do not predict bone mineral density in early postmenopausal Caucasian women. EPIC study group.
Topics: Alendronate; Bone Density; Cohort Studies; Double-Blind Method; Female; Humans; Middle Aged; Osteopo | 1998 |